Ind-Swift Laboratories Ltd

NSE: INDSWFTLAB · BSE: 532305 · Pharmaceuticals & Biotechnology · 39 announcements

Share price: ₹392.50
Market cap: ₹3,413 Cr
Revenue (annual): ₹641.3 Cr
Net profit (annual): ₹41.42 Cr
P/E (TTM): 59.5×Sector 47.4×
Promoter holding: 42.93%-0.06% QoQ
FII holding: 10.90%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 8 Capital Structure Change 6 Annual General Meeting 6 Price Movement Clarification 3 Financial Results 3 Board Meeting Date 3 Employee Stock Options 2 Capacity Expansion 2 Results Update 1 Management Change 1 Fund Raise 1 Earnings Call 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

3 Aug 2026 17:10 IST BSE

Board Meeting Date

Ind-Swift Laboratories Board Meeting Date

Ind-Swift Laboratories Ltd has scheduled a board meeting on August 10, 2026, to consider and approve its standalone and consolidated financial results for the quarter.

Read the filing ↗

7 Jul 2026 19:21 IST BSE

Board Meeting Date

Ind-Swift Laboratories Board Meeting Date

Ind-Swift Labs will hold a Board Meeting on July 10, 2026, to consider fund raising. Trading window is closed until 48 hours after the meeting.

Read the filing ↗

22 May 2026 17:21 IST BSE

Board Meeting Date

Ind-Swift Laboratories Board Meeting Date

Ind-Swift Laboratories scheduled a board meeting for May 28, 2026, to approve audited financial results. Investors should track the subsequent outcome for performance data.

Read the filing ↗